Skip to main content
Caplight Logo









RhyGaze AG

RhyGaze AG

Private
BaselFrontier & Industrial Techhttps://www.rhygaze.com/

Last Round

Series A

Jan 15, 2025

Total Funding Raised

$97.4M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

RhyGaze AG is a biotechnology company developing optogenetic-based gene therapies for retinal diseases causing blindness.

Sector

Frontier & Industrial Tech

Verticals

Sensors, Smart Manufacturing, IoT Hardware

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

industrial monitoringsafety systemsIIoTindustrial IoTsensor technologysite surveillancesmart manufacturingoperational safetyhazard detectionfactory automationindustrial automationfacility managementpredictive maintenance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RhyGaze AG Comparables

Compare RhyGaze AG with similar companies based on industry and business-model similarity.

No public comparables are available for RhyGaze AG. Request access to learn about comparables coverage.

Request access

RhyGaze AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 15, 2025
SeedJul 17, 2024

Key People

Founding team and executive leadership

Heather Floyd

Chief Operating Officer

Executive Team

RhyGaze AG Investors

Notable investors and investment history

RhyGaze AG investors
InvestorRounds
GVSeries A
ARCH Venture PartnersSeries A
F-Prime CapitalSeries A
BioGeneration VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 26, 2026

    Grew 113% QoQ, from 8 to 17 employees.

  • Aug 24, 2026

    Open roles increased to 15, 2.3x the trailing average.

RhyGaze AG Filings

Explore SEC and related filing metadata, where available.

RhyGaze AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RhyGaze AG's valuation, stock price, and market status.

Is RhyGaze AG a public or private company?

RhyGaze AG is a private company.

What is the current stock price of RhyGaze AG?

RhyGaze AG is a private company with no public stock price. No recent secondary market data is available.

How much is RhyGaze AG worth (valuation)?

Valuation information for RhyGaze AG is not publicly available.

Can I buy RhyGaze AG stock?

RhyGaze AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RhyGaze AG's last funding round?

RhyGaze AG's most recent funding round was Series A on January 15, 2025.

Who are the main investors in RhyGaze AG?

Key investors in RhyGaze AG include GV, ARCH Venture Partners, F-Prime Capital, BioGeneration Ventures.

Will RhyGaze AG IPO soon?

No public IPO plans have been announced for RhyGaze AG.

How can I track RhyGaze AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RhyGaze AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range23
Year Founded2024
Last FundingJan 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?